| Dr Stefani D Hass, PHARMD | |
|
3325 University Blvd E, Tuscaloosa, AL 35404-4339 | |
| (205) 556-3800 | |
| (205) 556-0142 |
| Full Name | Dr Stefani D Hass |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3325 University Blvd E, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902976244 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15552 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stefani D Hass, PHARMD 4980 Ross Cir, Northport, AL 35475-4490 Ph: (205) 266-1021 | Dr Stefani D Hass, PHARMD 3325 University Blvd E, Tuscaloosa, AL 35404-4339 Ph: (205) 556-3800 |
News Archive
For the third of all epilepsy patients who don't respond to medication, an alternative is to locate the small cluster of neurons that act as the seed of a seizure's aberrant electrical activity and surgically remove it. Unfortunately, such surgeries often fail to bring any relief. The ability to reliably pinpoint the anatomical source of seizures, different for each patient, remains elusive.
Leading medical experts today [Thursday 27 November] warn that rising numbers of deaths from liver disease - already the UK's third commonest cause of premature death - will be unavoidable without radical improvements in treatment and detection services, and tougher government policies to control the excessive alcohol use and obesity responsible for much of the national burden of liver disease.
Though there are signs the H1N1 (swine flu) has peaked in the U.S. and Canada, a WHO flu expert said Thursday it is too early to declare the pandemic over, Canadian Press reports.
A team led by a psychiatrist at the University of California, Riverside, has tested the orally administered investigational medication ecopipam on adults who stutter in an open-label, uncontrolled clinical trial and found that it reduced their stuttering symptoms from the start of therapy after eight weeks of dosing.
The current study used data on the durability of immunity among evolutionarily close coronavirus relatives of SARS-CoV-2 to estimate times to reinfection.
› Verified 2 days ago
Vito J Carruba, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3325 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-556-3800 Fax: 205-556-0142 | |
Brittany Nicole Barnes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Dr. Shelia Renee Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-9647 | |
Mr. Mike Pritchett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4400 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-6188 Fax: 205-553-6348 | |
Samantha Beams I, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3611 Rice Mine Rd Ne Lot 140, Tuscaloosa, AL 35406 Phone: 205-393-5876 | |
Mr. Jamie Floyd Sullivan, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Mr. Robert Shane Ballard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-9477 Fax: 205-553-9773 |